查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1842000

美国抗体特异性检测市场：市场规模、份额、趋势分析（按产品/服务、技术、应用、最终用途划分）、细分市场预测（2025-2033 年）

U.S. Antibody Specificity Testing Market Size, Share & Trends Analysis Report, By Product & Services, By Technology, By Application, By End-use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

市场规模与趋势：

据估计，2024 年美国抗体特异性检测市值为 3.173 亿美元，预计到 2033 年将达到 5.926 亿美元，2025 年至 2033 年的复合年增长率为 7.39%。

市场成长主要受抗体疗法和诊断方法应用日益广泛以及对研究可重复性日益重视的推动。高通量筛检和流式细胞技术等检验方法的进步，以及美国强大的研究基础设施和资金支持，预计将进一步加速抗体技术的应用。

疾病负担日益加重

在美国，推动抗体特异性检测市场需求成长的主要因素之一是日益加重的疾病负担，尤其是癌症、自体免疫疾病和感染疾病的盛行率不断上升。抗体在识别疾病生物标记、监测疾病进展以及开发标靶治疗方法方面发挥关键作用。随着美国慢性病盛行率的持续增长，医疗保健提供者和研究人员越来越重视检验抗体的准确性和特异性，以确保诊断和治疗结果的可靠性。

此外，随着治疗策略越来越依赖生物标记主导的方法，个人化和精准医疗的兴起推动了对高特异性抗体的需求。抗体特异性检测能够筛选和检验可精准标靶化疾病路径且无交叉反应的抗体，从而改善患者预后并降低无效治疗的风险。在美国，检测技术的进步和强大的研发投入推动了对高品质、经验证抗体的需求不断增长，预计这将继续成为预测期内推动市场扩张的核心因素。

目录

第一章 分析方法和范围

第二章执行摘要

第三章 市场因素、趋势与范围

  • 市场关联性展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析

第四章：依产品/服务进行业务分析

  • 产品/服务仪錶板
  • 美国抗体特异性检测市场：按产品和服务分類的差异分析
  • 美国抗体特异性检测市场规模及趋势分析（按产品及服务划分）（2021-2033 年）
  • 产品
    • 产品市场（2021-2033）
    • 抗体
    • 管理和标准
    • 套件和试剂
    • 基因检验工具
  • 抗体检验和特异性测试服务
    • 抗体检验与特异性检测服务市场（2021-2033）

第五章：依技术进行业务分析

  • 技术仪錶板
  • 美国抗体特异性检测市场：依技术分類的差异分析
  • 美国抗体特异性检测市场规模及趋势分析（按技术划分）（2021-2033 年）
  • 基于免疫检测的技术
    • 免疫检测分析技术市场（2021-2033）
    • 西方印渍术
    • 免疫化学
    • 流式细胞技术
    • 其他的
  • 基于基因检验的技术
    • 基于基因检验的技术市场（2021-2033）
  • 基于微阵列的抗体技术
    • 基于微阵列的抗体技术市场（2021-2033）
  • 其他技术
    • 其他技术市场（2021-2033）

第六章：按应用程式进行业务分析

  • 特定用途的仪錶板
  • 美国抗体特异性检测市场：按应用分類的差异分析
  • 美国抗体特异性检测市场规模及应用趋势分析（2021-2033）
  • 研究与开发
    • 研发市场（2021-2033）
    • 药物研发
    • 蛋白质体学和生物标记发现
  • 临床诊断
    • 临床诊断市场（2021-2033）
    • 感染疾病
    • 肿瘤学
    • 免疫学与自体免疫疾病
    • 神经退化性疾病
    • 代谢紊乱
    • 其他的

第七章 依最终用途进行业务分析

  • 终端用户仪錶板
  • 美国抗体特异性检测市场：依最终用途分類的差异分析
  • 美国抗体特异性检测市场规模及趋势分析（按最终用途划分）（2021-2033 年）
  • 製药和生物技术公司
    • 医药和生物技术市场（2021-2033）
  • 学术研究机构
    • 学术研究机构市场（2021-2033）
  • 诊断实验室
    • 诊断实验室市场（2021-2033）
  • 其他用途
    • 其他终端用户市场（2021-2033 年）

第八章 竞争情势

  • 公司分类
  • 策略规划
  • 企业市场分析（2024）
  • 公司简介/上市公司
    • Danaher
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
    • Cell Signaling Technology, Inc.
    • BD
    • Novus Biologicals
    • OriGene Technologies, Inc.
    • Creative Diagnostics
    • GenScript
Product Code: GVR-4-68040-738-1

Market Size & Trends:

The U.S. antibody specificity testing market size was estimated at USD 317.3 million in 2024 and is projected to reach USD 592.6 million by 2033, growing at a CAGR of 7.39% from 2025 to 2033. The market growth is driven by the rising use of antibody-based therapeutics and diagnostics, coupled with the growing focus on research reproducibility. Advancements in validation methods such as high-throughput screening and flow cytometry, along with strong U.S. research infrastructure and funding support, are expected to accelerate adoption further.

Growing disease burden

One of the major factors driving demand in the U.S. antibody specificity testing market is the growing disease burden, particularly the rising prevalence of cancer, autoimmune disorders, and infectious diseases. These conditions have significantly increased the reliance on antibody-based diagnostics and therapeutics, as antibodies play a crucial role in identifying disease biomarkers, monitoring disease progression, and developing targeted treatment approaches. With the U.S. witnessing a steady increase in chronic disease incidence, healthcare providers and researchers are placing greater emphasis on validating the accuracy and specificity of antibodies to ensure reliable diagnostic and therapeutic outcomes.

Moreover, the shift toward personalized and precision medicine has amplified the need for highly specific antibodies, as treatment strategies increasingly depend on biomarker-driven approaches. Antibody specificity testing enables the selection and validation of antibodies that can accurately target disease pathways without cross-reactivity, thereby improving patient outcomes and reducing risks of ineffective treatment. This growing demand for high-quality, validated antibodies supported by advances in testing technologies and strong U.S. R&D investment will remain a core driver of market expansion throughout the forecast period.

U.S. Antibody Specificity Testing Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the U.S. antibody specificity testing market on the basis of product & services, technology, application, and end-use:

  • Product & Services Outlook (Revenue, USD Million, 2021 - 2033)
  • Products
    • Antibodies
    • Control & Standards
    • Kits & Reagents
    • Gene Validation Tools
  • Antibody Validation & Specificity Testing Services
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Immunoassay-based Technologies
    • Western Blotting
    • Immunochemistry
    • Flow Cytometry
    • Others
  • Genetic Validation-based Technologies
  • Microarray-based Antibody Technologies
  • Other Technologies
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Research & Development
    • Drug Discovery & Development
    • Proteomics & Biomarker Discovery
  • Clinical Diagnostics
    • Infectious Diseases
    • Oncology
    • Immunology & Autoimmune Disorders
    • Neurodegenerative Disorders
    • Metabolic Disorders
    • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Diagnostic Laboratories
  • Other End Use

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Product & Services
    • 1.1.2. Technology
    • 1.1.3. Application
    • 1.1.4. End Use
  • 1.2. Market Definitions
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Others
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing disease burden
      • 3.2.1.2. Advances in technologies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Technical complexity and reproducibility challenges
      • 3.2.2.2. High cost of advanced validation technologies
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Product & Services Business Analysis

  • 4.1. Product & Services Segment Dashboard
  • 4.2. U.S. Antibody Specificity Testing Market: Product & Services Movement Analysis
  • 4.3. U.S. Antibody Specificity Testing Market Size & Trend Analysis, by Product & Services, 2021 to 2033 (USD Million)
  • 4.4. Products
    • 4.4.1. Products Market, 2021 - 2033 (USD Million)
    • 4.4.2. Antibodies
      • 4.4.2.1. Antibodies Market, 2021 - 2033 (USD Million)
    • 4.4.3. Control & Standards
      • 4.4.3.1. Control & Standards Market, 2021 - 2033 (USD Million)
    • 4.4.4. Kits & Reagents
      • 4.4.4.1. Kits & Reagents Market, 2021 - 2033 (USD Million)
    • 4.4.5. Gene Validation Tools
      • 4.4.5.1. Gene Validation Tools Market, 2021 - 2033 (USD Million)
  • 4.5. Antibody Validation & Specificity Testing Services
    • 4.5.1. Antibody Validation & Specificity Testing Services Market, 2021 - 2033 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Product & Services Segment Dashboard
  • 5.2. U.S. Antibody Specificity Testing Market: Technology Movement Analysis
  • 5.3. U.S. Antibody Specificity Testing Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 5.4. Immunoassay-based Technologies
    • 5.4.1. Immunoassay-based Technologies Market, 2021 - 2033 (USD Million)
    • 5.4.2. Western Blotting
      • 5.4.2.1. Western Blotting Market, 2021 - 2033 (USD Million)
    • 5.4.3. Immunochemistry
      • 5.4.3.1. Immunochemistry Market, 2021 - 2033 (USD Million)
    • 5.4.4. Flow Cytometry
      • 5.4.4.1. Flow Cytometry Market, 2021 - 2033 (USD Million)
    • 5.4.5. Others
      • 5.4.5.1. Others Market, 2021 - 2033 (USD Million)
  • 5.5. Genetic Validation-based Technologies
    • 5.5.1. Genetic Validation-based Technologies Market, 2021 - 2033 (USD Million)
  • 5.6. Microarray-based Antibody Technologies
    • 5.6.1. Microarray-based Antibody Technologies Market, 2021 - 2033 (USD Million)
  • 5.7. Other Technologies
    • 5.7.1. Other Technologies Market, 2021 - 2033 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. U.S. Antibody Specificity Testing Market: Application Movement Analysis
  • 6.3. U.S. Antibody Specificity Testing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Research & Development
    • 6.4.1. Research & Development Market, 2021 - 2033 (USD Million)
    • 6.4.2. Drug Discovery & Development
      • 6.4.2.1. Drug Discovery & Development Market, 2021 - 2033 (USD Million)
    • 6.4.3. Proteomics & Biomarker Discovery
      • 6.4.3.1. Proteomics & Biomarker Discovery Market, 2021 - 2033 (USD Million)
  • 6.5. Clinical Diagnostics
    • 6.5.1. Clinical Diagnostics Market, 2021 - 2033 (USD Million)
    • 6.5.2. Infectious Diseases
      • 6.5.2.1. Infectious Diseases Market, 2021 - 2033 (USD Million)
    • 6.5.3. Oncology
      • 6.5.3.1. Oncology Market, 2021 - 2033 (USD Million)
    • 6.5.4. Immunology & Autoimmune Disorders
      • 6.5.4.1. Immunology & Autoimmune Disorders Market, 2021 - 2033 (USD Million)
    • 6.5.5. Neurodegenerative Disorders
      • 6.5.5.1. Neurodegenerative Disorders Market, 2021 - 2033 (USD Million)
    • 6.5.6. Metabolic Disorders
      • 6.5.6.1. Metabolic Disorders Market, 2021 - 2033 (USD Million)
    • 6.5.7. Others
      • 6.5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. U.S. Antibody Specificity Testing Market: End Use Movement Analysis
  • 7.3. U.S. Antibody Specificity Testing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Pharmaceutical and Biotechnology Companies
    • 7.4.1. Pharmaceutical and Biotechnology Companies Market, 2021 - 2033 (USD Million)
  • 7.5. Academic and Research Institutions
    • 7.5.1. Academic and Research Institutions Market, 2021 - 2033 (USD Million)
  • 7.6. Diagnostic Laboratories
    • 7.6.1. Diagnostic Laboratories Market, 2021 - 2033 (USD Million)
  • 7.7. Other End Use
    • 7.7.1. Other End Use Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Danaher
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Thermo Fisher Scientific Inc.
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Bio-Rad Laboratories, Inc.
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Merck KGaA
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Cell Signaling Technology, Inc.
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. BD
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Novus Biologicals
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. OriGene Technologies, Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Creative Diagnostics
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. GenScript
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 U.S. Antibody Specificity Testing Market, By Product & Services, 2021 - 2033 (USD Million)
  • Table 5 U.S. Antibody Specificity Testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 6 U.S. Antibody Specificity Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 7 U.S. Antibody Specificity Testing Market, By End use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 U.S. antibody specificity testing market segmentation
  • Fig. 8 Market snapshot, 2024
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis
  • Fig. 11 Market restraint relevance analysis
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 U.S. antibody specificity testing market: Product & services movement analysis
  • Fig. 15 U.S. antibody specificity testing market, for product, 2021 - 2033 (USD Million)
  • Fig. 16 U.S. antibody specificity testing market, for kits & reagents, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. antibody specificity testing market, for antibodies, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. antibody specificity testing market, for control & standards, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. antibody specificity testing market, for gene validation tools, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. antibody specificity testing market, for antibody validation & specificity testing services, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. antibody specificity testing market: Technology movement analysis
  • Fig. 22 U.S. antibody specificity testing market, for immunoassay-based technologies, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. antibody specificity testing market, for western blotting, 2021 - 2033 (USD Million)
  • Fig. 24 U.S. antibody specificity testing market, for immunochemistry, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. antibody specificity testing market, for flow cytometry, 2021 - 2033 (USD Million)
  • Fig. 26 U.S. antibody specificity testing market, for others, 2021 - 2033 (USD Million)
  • Fig. 27 U.S. antibody specificity testing market, for genetic validation-based technologies, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. antibody specificity testing market, for microarray-based antibody technologies, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. antibody specificity testing market, for other technologies, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. antibody specificity testing market: Application movement analysis
  • Fig. 31 U.S. antibody specificity testing market, for research and development, 2021 - 2033 (USD Million)
  • Fig. 32 U.S. antibody specificity testing market, for drug discovery & development, 2021 - 2033 (USD Million)
  • Fig. 33 U.S. antibody specificity testing market, for proteomics & biomarker discovery, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. antibody specificity testing market, for clinical diagnostics, 2021 - 2033 (USD Million)
  • Fig. 35 U.S. antibody specificity testing market, for oncology, 2021 - 2033 (USD Million)
  • Fig. 36 U.S. antibody specificity testing market, for infectious diseases, 2021 - 2033 (USD Million)
  • Fig. 37 U.S. antibody specificity testing market, for immunology & autoimmune disorders, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. antibody specificity testing market, for neurodegenerative disorders, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. antibody specificity testing market, for metabolic disorders, 2021 - 2033 (USD Million)
  • Fig. 40 U.S. antibody specificity testing market, for others, 2021 - 2033 (USD Million)
  • Fig. 41 U.S. antibody specificity testing market: End Use movement analysis
  • Fig. 42 U.S. antibody specificity testing market, for academic and research institutions, 2021 - 2033 (USD Million)
  • Fig. 43 U.S. antibody specificity testing market, for pharmaceutical and biotechnology companies, 2021 - 2033 (USD Million)
  • Fig. 44 U.S. antibody specificity testing market, for diagnostic laboratories, 2021 - 2033 (USD Million)
  • Fig. 45 U.S. antibody specificity testing market, for other end use, 2021 - 2033 (USD Million)